Payment to participants in pediatric research: Variation in IRB members' a ttitudes

IRB Ethics and Human Research

Volumn 35, Issue 5, 2013, Pages 9-13

  Crites, Joshua S ^a   Harter, Thomas D ^b   Furman, Lydia M ^c   Daly, Barbara J ^d  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b Gunderson Lutheran Medical Foundation   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTHMA; ATTITUDE; CHILD; CLINICAL TRIAL; ECONOMICS; HEALTH CARE SURVEY; HUMAN; INFORMATION PROCESSING; MULTICENTER STUDY; PEDIATRICS; PROFESSIONAL STANDARD; REMUNERATION; RESEARCH SUBJECT; UNITED STATES; ARTICLE;

ASTHMA; ATTITUDE; CHILD; ETHICS COMMITTEES, RESEARCH; FOCUS GROUPS; HEALTH CARE SURVEYS; HUMANS; PEDIATRICS; REMUNERATION; RESEARCH SUBJECTS; UNITED STATES;

EID: 84892880730     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Ramsey, BW. Appropriate compensation of pediatric research participants: Thoughts from an Institute of Medicine Committee report. Journal of Pediatrics 2006;49(1 Suppl):S15-19;
2. Field MJ, Behrman RE. Payments related to children's participation in clinical research. In: Institute of Medicine (US) Committee on Clinical Research Involving Children. Ethical Conduct of Clinical Research Involving Children. Washington, DC: National Academies Press, 2004;
3. Weise KL, Smith ML, Maschke KJ, Copeland HL. National practices regarding payment to research subjects for participating in pediatric research. Pediatrics 2002;110(3):577-582.
4. U. S. Department of Health and Human Services. Protection of Human Subjects 45 CFR 46.
5. U. S. Food and Drug Administration. 11 Protection of Human Subjects 21 CRF 50.
6. Office for Human Research Protections. IRB Guidebook. Chapter III. 1993. http://www.hhs.gov/ohrp/archive/irb/irb-guidebook.htm.
7. U. S. Food and Drug Administration. Payment to Research Subjects-Information Sheet. Guidance for Institutional Review Boards and Clinical Investigators. 1998. http://www.fda.gov/regulatoryinformation/ guidances/ucmi 26429.htm.
8. Largent EA, Grady C, Miller FG, Wertheimer A. Money, coercion, and undue inducement: Attitudes about payments to research participants. IRB: Ethics & Human Research 2012;34(1):1-8.
9. Silverman H, Hull SC, Sugarman J. Variability among institutional review boards' decisions within the context of a multicenter trial. Critical Care Medicine 2001;29(2):235-241;
10. Abbott L, Grady C. A systematic review of the empirical literature evaluating IRBs: What we know and what we still need to learn. Journal of Empirical Research on Human Research Ethics 2011; vi(1):3-19;
11. Candilis PJ, Lidz CW, Arnold RM. The need to understand IRB deliberations. IRB: Ethics & Human Research 2006;28(1):1-5.
12. Tisher CL and Reiss NS. Pediatric drug-trial recruitment: enticement without coercion. Pediatrics 2011;127(5):949-954.